Human Molecular Genetics Advance Access published online on July 21, 2005
Human Molecular Genetics, doi:10.1093/hmg/ddi254
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pediatrics, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208064, New Haven, CT 06520-8064, USA
* To whom correspondence should be addressed. Ankyrin defects are the most common cause of hereditary spherocytosis (HS). In some HS patients, mutations in the ankyrin promoter have been hypothesized to lead to decreased ankyrin mRNA synthesis. The ankyrin erythroid promoter is a member of the most common class of mammalian promoters which lack conserved TATA, initiator, or other promoter cis elements, have high G + C content, functional Sp1 binding sites, and multiple transcription initiation sites. We identified a novel ankyrin gene promoter mutation, a TG deletion adjacent to a transcription initiation site, in a patient with ankyrin-linked HS and analyzed its effects on ankyrin expression. In vitro, the mutant promoter directed decreased levels of gene expression, altered transcription initiation site utilization, and exhibited defective TATA-binding protein (TBP) binding and TFIID complex formation. In a transgenic mouse model, the mutant ankyrin promoter led to abnormalities in gene expression, including decreased expression of a reporter gene and altered transcription initiation site utilization. These data indicate that the mutation alters ankyrin gene transcription and contributes to the HS phenotype by decreasing ankyrin gene synthesis via disruption of TFIID complex interactions with the ankyrin core promoter. These studies support the model that in promoters that lack conserved cis elements, the TFIID complex directs preinitiation complex formation at specific sites in core promoter DNA and provide the first evidence that disruption of TBP binding and TFIID complex formation in this type of promoter leads to alterations in start site utilization, decreased gene expression, and a disease phenotype in vivo.
Received June 3, 2005
Revised July 8, 2005
Accepted July 8, 2005
Article
A Dinucleotide Deletion in the Ankyrin Promoter Alters Gene Expression, Transcription Initiation and TFIID Complex Formation in Hereditary Spherocytosis
2 Hematopoiesis Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
3 Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA
4 Universitäts-Kinderklinik Zürich, Zurich, Switzerland CH-8032
Patrick G. Gallagher, E-mail: patrick.gallagher{at}yale.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?